Haemonetics Free Cash Flow 2010-2024 | HAE
Haemonetics free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Haemonetics Annual Free Cash Flow |
| 2024 |
117.27 |
| 2023 |
164.48 |
| 2022 |
77.78 |
| 2021 |
73.58 |
| 2020 |
126.23 |
| 2019 |
43.13 |
| 2018 |
148.31 |
| 2017 |
86.43 |
| 2016 |
20.10 |
| 2015 |
5.41 |
| 2014 |
66.36 |
| 2013 |
24.85 |
| 2012 |
63.12 |
| 2011 |
78.25 |
| 2010 |
76.15 |
| 2009 |
62.37 |
| Haemonetics Quarterly Free Cash Flow |
| 2024-12-31 |
62.34 |
| 2024-09-30 |
26.86 |
| 2024-06-30 |
-12.72 |
| 2024-03-31 |
117.27 |
| 2023-12-31 |
87.49 |
| 2023-09-30 |
102.34 |
| 2023-06-30 |
11.81 |
| 2023-03-31 |
164.48 |
| 2022-12-31 |
102.87 |
| 2022-09-30 |
55.15 |
| 2022-06-30 |
-2.98 |
| 2022-03-31 |
77.78 |
| 2021-12-31 |
44.24 |
| 2021-09-30 |
7.91 |
| 2021-06-30 |
-15.03 |
| 2021-03-31 |
73.58 |
| 2020-12-31 |
82.94 |
| 2020-09-30 |
25.83 |
| 2020-06-30 |
4.52 |
| 2020-03-31 |
126.23 |
| 2019-12-31 |
89.96 |
| 2019-09-30 |
30.55 |
| 2019-06-30 |
-5.32 |
| 2019-03-31 |
43.13 |
| 2018-12-31 |
35.71 |
| 2018-09-30 |
5.13 |
| 2018-06-30 |
-4.14 |
| 2018-03-31 |
148.31 |
| 2017-12-31 |
108.65 |
| 2017-09-30 |
69.55 |
| 2017-06-30 |
25.69 |
| 2017-03-31 |
86.43 |
| 2016-12-31 |
66.42 |
| 2016-09-30 |
28.53 |
| 2016-06-30 |
8.30 |
| 2016-03-31 |
20.10 |
| 2015-12-31 |
-4.86 |
| 2015-09-30 |
-13.08 |
| 2015-06-30 |
-14.88 |
| 2015-03-31 |
5.41 |
| 2014-12-31 |
-28.27 |
| 2014-09-30 |
-25.52 |
| 2014-06-30 |
-23.28 |
| 2014-03-31 |
66.36 |
| 2013-12-31 |
44.53 |
| 2013-09-30 |
15.20 |
| 2013-06-30 |
0.88 |
| 2013-03-31 |
24.85 |
| 2012-12-31 |
9.14 |
| 2012-09-30 |
-0.51 |
| 2012-06-30 |
-7.64 |
| 2012-03-31 |
63.12 |
| 2011-12-31 |
44.90 |
| 2011-09-30 |
28.83 |
| 2011-06-30 |
15.35 |
| 2011-03-31 |
78.25 |
| 2010-12-31 |
56.66 |
| 2010-09-30 |
20.46 |
| 2010-06-30 |
-1.59 |
| 2010-03-31 |
76.15 |
| 2009-12-31 |
49.72 |
| 2009-09-30 |
28.98 |
| 2009-06-30 |
4.70 |
| 2009-03-31 |
62.37 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$3.164B |
$1.309B |
|
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
|
